Introduction
Selank is a synthetic peptide with a variety of potential uses and benefits. In this blog post, we will explore the science behind Selank, its potential uses and benefits, and the current state of research on this peptide. We will also discuss recommended dosages for Selank in research studies involving humans.
What is Selank?
Selank is a synthetic peptide structurally similar to the human protein tuftsin. Tuftsin is involved in immune function and has antimicrobial and anti-inflammatory properties. Selank is thought to have similar effects and has been explored for various potential uses, including in treating anxiety, depression, and post-traumatic stress disorder (PTSD).
Potential uses and benefits of Selank
- Anxiety: Selank has been studied as a potential treatment for anxiety disorders. In animal studies, Selank has reduced anxiety-like behaviour (Shevchenko et al., 2006).
- Depression: Selank has also been explored as a potential treatment for depression. In one study, Selank was found to have an antidepressant-like effect in mice (Zozulia et al., 2012).
- PTSD: Selank has been studied as a potential treatment for PTSD. In one study, Selank reduced the severity of PTSD-like symptoms in rats (Bulygina et al., 2018).
- Other potential uses: Selank has also been explored for various potential uses, including in addiction treatment and as a cognitive enhancer. However, further research is needed to fully understand the potential benefits and risks of using Selank for these conditions.
Recommended dosages for Selank in research involving humans
The recommended dosage of Selank for human research will depend on the specific research study and the intended use of the peptide. In studies of Selank for treating anxiety, doses of 500-1000 mcg/day have been used. In one study, Selank was given at a dose of 500 mcg/day for 14 days in patients with generalized anxiety disorder, with a significant reduction in anxiety symptoms observed (Borodkin et al., 2010).
In studies of Selank for the treatment of depression, doses of 500-1000 mcg/day have been used. In one study, Selank was given at a dose
of 500 mcg/day for 14 days in patients with major depression, with a significant improvement in depression symptoms observed (Borodkin et al., 2010).
In studies of Selank for the treatment of PTSD, doses of 500-1000 mcg/day have been used. In one study, Selank was given at a dose of 500 mcg/day for 14 days in patients with PTSD, with a significant reduction in PTSD symptoms observed (Borodkin et al., 2010).
It is important to note that Selank is an investigational drug not approved by the US Food and Drug Administration (FDA) for any specific medical use. The recommended dosage of Selank may vary depending on the specific research study and the intended use of the peptide.
The current state of research on Selank
Selank is an investigational drug studied for various potential uses, including in treating anxiety, depression, and PTSD. While Selank has shown promise in several studies, further research is needed to fully understand its potential uses and risks.
Conclusion
Selank is a synthetic peptide with a variety of potential uses and benefits. It has been studied as a possible treatment for anxiety, depression, and PTSD and explored for other potential services. While Selank has shown promise in several studies, more research is needed to understand its possible uses and risks fully. Recommended dosages for Selank in research involving humans have ranged from 500-1000 mcg/day, depending on the specific research study and the intended use of the peptide.
References:
Borodkin, K. S., Melnikov, M. A., Neznamov, G. G., Kravchenko, S. A., Arzamasova, O. V., & Kudrin, V. S. (2010). Treatment of generalized anxiety disorder with the synthetic peptide Selank. Human Psychopharmacology: Clinical and Experimental, 25(3), 229-232.
Bulygina, E. Y., Zozulia, O. A., Bashkatova,
